Niclas Eriksson, PhD
机构: Biostatistician, Uppsala Clinical Research Center, UCR
每年引用次数
引用次数
引用: 12,420
H-指数: 34
I10-指数 : 65
出版物: 148
1
2012
Controllerarbete på Scania : En studie kring controllerns dagliga arbete
Ludvig Larruy , Niclas Eriksson
2011
Beslutsfattarens egenskaper i relation till internationaliseringsprocessen : En studie av ett svenskt småföretag med växande varuexport
Fredrik Collenius , Niclas Eriksson
2008
Genetic determinants of warfarin response, efficacy and safety : a RE-LY genomics substudy
Mia Wadelius , Claes Wadelius , Niclas Eriksson , Tomas Axelsson
2012
Riskuppfattning och riskbenägenhet hos entreprenörer : En studie av bakomliggande faktorer i entreprenörers personlighet
Niclas Eriksson , Fredric Sjögren
2005
Adaption of the Agricultural Non-point Source Pollution Model to the Morsa Watershed
Niclas Eriksson
1
2003
Waran doseras bättre efter genanalys
Mia Wadelius , Niclas Eriksson
Läkartidningen 111 22 -22
2014
Are There Any Causal Relations Between Growth Differentiation Factor 15 and Outcomes in Patients With Acute Coronary Syndrome? : - A Report From the Plato Gwas Study
Emil Hagström , Niclas Eriksson , åsa Johansson , Maria Bertilsson
Circulation 128 ( 22)
1
2013
Evaluation of the Effect of Interleukin 18 Associated Genetic Polymorphisms on Risk of Cardiovascular Events in Patients With Acute Coronary Syndrome
Agneta Siegbahn , åsa Johansson , Niclas Eriksson , Emil Hagström
Circulation 128 ( 22)
2013
Preoperative lung function tests as a predictor for atelectasis in morbidly obese patients during anesthesia
Henrik Reinius , Filip Fredén , Hans Hedenström , Anders Larsson
2015
Whole exome sequencing in individuals with statin-induced myopathy
Mia Wadelius , Niclas Eriksson , A. Alfirevic , D. Carr
Drug Safety 40 ( 10) 1026 -1026
2017
Genome‐Wide Association Study of Pandemrix‐Induced Narcolepsy in Sweden – A Possible Role for Glial Derived Neurotrophic Factor (GDNF)
Mia Wadelius , Niclas Eriksson , P. K. E. Magnusson , Pär Hallberg
Basic & Clinical Pharmacology & Toxicology 123 12 -13
2018
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
Winfried März , Winfried März , Winfried März , Emil Hagström
PLOS Medicine 18 ( 1)
44
2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
Stefan J Schunk , Marcus E Kleber , Winfried März , Shichao Pang
European Heart Journal 42 ( 18) 1742 -1756
37
2021
Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19
James F Wilson , James F Wilson , Dirk S Paul , Dirk S Paul
medRxiv
8
2021
Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis.
Niclas Eriksson , Agneta Siegbahn , Bakhtawar K. Mahmoodi , Karina Meijer
Journal of the American Heart Association 10 ( 11)
2021
Association of Chromosome 9p21 with Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data
Riyaz S. Patel , Amand F. Schmidt , Vinicius Tragante , Raymond O. McCubrey
Circulation: Genomic and Precision Medicine 12 ( 4) 002471
8
2019
Subsequent Event Risk in Individuals with Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium.
Jean-Claude Tardif , Jurriën M. ten Berg , Jacob Tfelt-Hansen , George Thanassoulis
Circulation: Genomic and Precision Medicine 12 ( 4) 145 -160
23
2019
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.
Lasse Folkersen , Stefan Gustafsson , Qin Wang , Daniel Hvidberg Hansen
Nature metabolism 2 ( 10) 1135 -1148
175
2020